Not Valid for Submission
C91.0 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of acute lymphoblastic leukemia [all]. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding for Acute lymphoblastic leukemia [ALL]
Non-specific codes like C91.0 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for acute lymphoblastic leukemia [all]:
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C91.0:
- Codes in subcategory C91.0- should only be used for T-cell and B-cell precursor leukemia
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C91.0 are found in the index:
- MYELOID LYMPHOID LEUKEMIA PROTEIN-. myeloid lymphoid leukemia protein is a transcription factor that maintains high levels of homeotic gene expression during development. the gene for myeloid lymphoid leukemia protein is commonly disrupted in leukemia and combines with over 40 partner genes to form fusion oncogene proteins.
- ADP RIBOSYL CYCLASE 1-. a bifunctional enzyme that catalyzes the synthesis and hydrolysis of cyclic adp ribose cadpr from nad+ to adp ribose. it is a cell surface molecule which is predominantly expressed on lymphoid cells and myeloid cells.
- PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA LYMPHOMA-. a neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. it is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
Information for Patients
Acute Lymphocytic Leukemia
What is leukemia?
Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job:
- White blood cells help your body fight infection
- Red blood cells deliver oxygen from your lungs to your tissues and organs
- Platelets help form clots to stop bleeding
When you have leukemia, your bone marrow makes large numbers of abnormal cells. This problem most often happens with white blood cells. These abnormal cells build up in your bone marrow and blood. They crowd out the healthy blood cells and make it hard for your cells and blood to do their work.
What is acute lymphocytic leukemia (ALL)?
Acute lymphocytic leukemia is a type of acute leukemia. It's also called ALL and acute lymphoblastic leukemia. "Acute" means that it usually gets worse quickly if it's not treated. ALL is the most common type of cancer in children. It can also affect adults.
In ALL, the bone marrow makes too many lymphocytes, a type of white blood cell. These cells normally help your body fight infection. But in ALL, they are abnormal and cannot fight infection very well. They also crowd out the healthy cells, which can lead to infection, anemia, and easy bleeding. These abnormal cells can also spread to other parts of the body, including the brain and spinal cord.
What causes acute lymphocytic leukemia (ALL)?
ALL happens when there are changes in the genetic material (DNA) in bone marrow cells. The cause of these genetic changes is unknown. However, there are certain factors that raise your risk of ALL.
Who is at risk for acute lymphocytic leukemia (ALL)?
The factors that raise your risk of ALL include
- Being male
- Being white
- Being over age 70
- Having had chemotherapy or radiation therapy
- Having been exposed to high levels of radiation
- Having certain genetic disorders, such as Down syndrome
What are the symptoms of acute lymphocytic leukemia (ALL)?
The signs and symptoms of ALL include
- Weakness or feeling tired
- Fever or night sweats
- Easy bruising or bleeding
- Petechiae, which are tiny red dots under the skin. They are caused by bleeding.
- Shortness of breath
- Weight loss or loss of appetite
- Pain in the bones or stomach
- Pain or feeling of fullness below the ribs
- Swollen lymph nodes - you may notice them as painless lumps in the neck, underarm, stomach, or groin
- Having had many infections
How is acute lymphocytic leukemia (ALL) diagnosed?
Your health care provider may use many tools to diagnose ALL and figure out which subtype you have:
- A physical exam
- A medical history
- Blood tests, such as
- Complete blood count (CBC) with differential
- Blood chemistry tests such as a basic metabolic panel (BMP), comprehensive metabolic panel (CMP), kidney function tests, liver function tests, and electrolyte panel
- Blood smear
- Bone marrow tests. There are two main types - bone marrow aspiration and bone marrow biopsy. Both tests involve removing a sample of bone marrow and bone. The samples are sent to a lab for testing.
- Genetic tests to look for gene and chromosome changes
If you are diagnosed with ALL, you may have additional tests to see whether the cancer has spread. These include imaging tests and a lumbar puncture, which is a procedure to collect and test cerebrospinal fluid (CSF).
What are the treatments for acute lymphocytic leukemia (ALL)?
Treatments for ALL include
- Radiation therapy
- Chemotherapy with stem cell transplant
- Targeted therapy, which uses drugs or other substances that attack specific cancer cells with less harm to normal cells
Treatment is usually done in two phases:
- The goal of the first phase is to kill the leukemia cells in the blood and bone marrow. This treatment puts the leukemia into remission. Remission means that the signs and symptoms of cancer are reduced or have disappeared.
- The second phase is known as post-remission therapy. Its goal is to prevent a relapse (return) of the cancer. It involves killing any remaining leukemia cells that may not be active but could begin to regrow.
Treatment during both phases also usually includes central nervous system (CNS) prophylaxis therapy. This therapy helps prevent the spread of leukemia cells to the brain and spinal cord. It may be high dose chemotherapy or chemotherapy injected into the spinal cord. It also sometimes includes radiation therapy.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Leukemia-Patient Version Learn about acute lymphoblastic leukemia risk factors, symptoms, tests to diagnose, factors affecting prognosis, and treatment.
[Learn More in MedlinePlus]